The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Mice, Inbred NOD

This is a "connection" page, showing publications Olatoyosi Odenike has written about Mice, Inbred NOD.
Connection Strength

0.101
  1. Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. In Vivo. 2022 Jul-Aug; 36(4):1615-1627.
    View in: PubMed
    Score: 0.052
  2. Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. Mol Cell. 2021 09 16; 81(18):3833-3847.e11.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.